Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Cell

• Publication date

  2017-12-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2017.10.016PMID 29198914PMCID PMC5730343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.

  2017cited by this paper
• Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.

  2017cited by this paper
• 67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice.

  2017cited by this paper
• A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo

  2017cited by this paper
• Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome

  2016cited by this paper
• Integrins in glioblastoma: Still an attractive target?

  2016cited by this paper
• Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness.

  2016cited by this paper
• A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies

  2016cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescence.

  2015cited by this paper
• PANTHER version 10: expanded protein families and functions, and analysis tools

  2015cited by this paper
• AMPK modulates Hippo pathway activity to regulate energy homeostasis

  2015cited by this paper
• End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma.

  2015cited by this paper
• Cancer stem cells in glioblastoma

  2015cited by this paper
• The emerging roles of YAP and TAZ in cancer

  2015cited by this paper
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

  2014cited by this paper
• An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition

  2014cited by this paper
• Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary gland.

  2014cited by this paper
• Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

  2014cited by this paper
• Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides

  2014cited by this paper
• SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

  2013cited by this paper
• Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3

  2013cited by this paper
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake

  2013cited by this paper
• The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.

  2011cited by this paper
• Tumor angiogenesis: molecular pathways and therapeutic targets

  2011cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

  2010cited by this paper
• Integrins in cancer: biological implications and therapeutic opportunities

  2010cited by this paper
• Mining for coexpression across hundreds of datasets using novel rank aggregation and visualization methods

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

  2007cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cited by this paper
• Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

  2003cited by this paper
• Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.

  1994cited by this paper
• Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.

  1991cited by this paper
• Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor.

  1987cited by this paper
• Prediction of survival in glioma patients by means of positron emission tomography.

  1985cited by this paper
• Bmc Medical Genomics Gene Expression Analysis of Glioblastomas Identifies the Major Molecular Basis for the Prognostic Benefit of Younger Age

  year unknowncited by this paper

• Mechanical regulation of metabolism, epigenetics, and their interplay

  2026cites this paper
• Unraveling the αVβ5–GLUT5 axis in breast cancer: linking extracellular matrix signaling to fructose metabolism: a scoping review

  2026cites this paper
• Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas.

  2025cites this paper
• Matrix composition and glucose availability cooperatively determine cancer spheroid bioenergetics in 3D hydrogels

  2025cites this paper
• Matrix stiffness modulates YAP-mediated glycolysis and proliferation in human corneal endothelial cells.

  2025cites this paper
• From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization

  2025cites this paper
• Tissue stiffness heterogeneity in the jaw and temporomandibular joint: its impact on tumor metabolism and considerations for in vitro model development

  2025cites this paper
• Solute carrier family 2 member 3: A central mediator in aerobic glycolysis contributing to tumor malignant progression

  2025influential citation
• Phenotypic variations in glioma stem cells: regulatory mechanisms and implications for therapeutic strategies

  2025cites this paper
• Exploring YAP1-TEAD interaction in multi-pathway regulation: potential repairing efficacy for bone defect

  2025cites this paper
• Mitochondrial Calcium Uniporter Links Acetyl-CoA Metabolism and H3K27 Acetylation to Maintain Glioblastoma Stem Cells.

  2025cites this paper
• A STAT3/integrin axis accelerates pancreatic cancer initiation and progression

  2025cites this paper
• Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties

  2025cites this paper
• YAP/TAZ in the nervous system: Key regulatory and therapeutic implications in neurological disorders.

  2025cites this paper
• Pan-cancer analysis of ITGB3 as a potential prognostic and immunological biomarker

  2025cites this paper
• A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

  2025cites this paper
• Pharmacological regulators of Hippo pathway: Advances and challenges of drug development

  2025cites this paper
• Lactate-Mediated Epigenetic and Immunometabolic Reprogramming in Glioma: An Emerging Axis Linking Metabolism to Tumor Progression

  2025cites this paper
• The HIF-1α/PLOD2 axis integrates extracellular matrix organization and cell metabolism leading to aberrant musculoskeletal repair

  2024cites this paper
• Clotting Promotes Glioma Growth and Infiltration Through Activation of Focal Adhesion Kinase

  2024cites this paper
• Glut3 promotes cellular O-GlcNAcylation as a distinctive tumor-supportive feature in Treg cells

  2024cites this paper
• Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2.

  2024cites this paper
• Targeting the Leloir Pathway with Galactose-Based Antimetabolites in Glioblastoma

  2024cites this paper
• Insights into Metabolic Reprogramming in Tumor Evolution and Therapy

  2024cites this paper
• Niobium Nanoparticles Activates Endothelial Tip Cells and Promotes Angiogenesis by FOXA1-PAK4-YAP Signaling Pathway

  2024cites this paper
• Integrins in cancer stem cells

  2024cites this paper
• Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics.

  2024cites this paper
• Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages

  2024cites this paper
• The Role of αvβ3 Integrin in Cancer Therapy Resistance

  2024cites this paper
• Cancer signaling, cell/gene therapy, diagnosis and role of nanobiomaterials

  2024cites this paper
• TCF1–LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases

  2024cites this paper
• GLUT and HK: two primary and essential key players in Tumor glycolysis.

  2024cites this paper
• Glioblastoma Therapy: Past, Present and Future

  2024cites this paper
• Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation

  2023cites this paper
• The role of thrombomodulin in modulating ITGB3 expression and its implications for triple‐negative breast cancer progression

  2023cites this paper
• Prognostic significance and expression pattern of glucose related genes in breast cancer: A comprehensive computational biology approach

  2023cites this paper
• Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance

  2023cites this paper
• Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiation.

  2023cites this paper
• Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential

  2023cites this paper
• Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma

  2023cites this paper
• Dynamic links between mechanical forces and metabolism shape the tumor milieu.

  2023cites this paper
• Targeted CRISPR activation and knockout screenings identify novel drug transporters

  2023cites this paper
• Screening a DNA Aptamer Specifically Targeting Integrin β3 and Partially Inhibiting Tumor Cell Migration

  2023cites this paper
• Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters

  2023cites this paper
• PKM2 rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance.

  2023cites this paper
• Glioblastoma Metabolism: Insights and Therapeutic Strategies

  2023cites this paper
• New insights into the ambivalent role of YAP/TAZ in human cancers

  2023cites this paper
• Metabolic Rewiring in Adult-Type Diffuse Gliomas

  2023cites this paper
• The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis

  2023cites this paper
• The Hippo signaling pathway: from multiple signals to the hallmarks of cancers

  2023cites this paper
• Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance

  2023cites this paper
• ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5

  2023cites this paper
• Cancer cell intrinsic TIM-3 induces glioblastoma progression

  2022cites this paper
• Regulation of Hippo signaling by metabolic pathways in cancer.

  2022cites this paper
• The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer

  2022cites this paper
• Glioblastoma Invasiveness and Collagen Secretion Are Enhanced by Vitamin C

  2022cites this paper
• YAP Dictates Mitochondrial Redox Homeostasis to Facilitate Obesity‐Associated Breast Cancer Progression

  2022cites this paper
• NOX4 regulates TGFβ‐induced proliferation and self‐renewal in glioblastoma stem cells

  2022cites this paper
• KRAS Addiction Promotes Cancer Cell Adaptation in Harsh Microenvironment Through Macropinocytosis.

  2022cites this paper
• Targeting Oncometabolism to Maximize Immunotherapy in Malignant Brain Tumors

  2022cites this paper
• Metabolism in the progression and metastasis of brain tumors

  2022cites this paper
• Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma

  2022cites this paper
• Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis

  2022cites this paper
• Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway

  2022cites this paper
• PAK4 in cancer development: Emerging player and therapeutic opportunities.

  2022cites this paper
• Identification of genes from ten oncogenic pathways associated with mortality and disease progression in glioblastoma

  2022cites this paper
• Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities

  2022cites this paper
• p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond

  2022cites this paper
• Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma

  2022cites this paper
• Reciprocal regulation of actin filaments and cellular metabolism.

  2022cites this paper
• Mechanosensing in macrophages and dendritic cells in steady-state and disease

  2022cites this paper
• Endothelial GLUTs and vascular biology.

  2022cites this paper
• Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells

  2021cites this paper
• Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy.

  2021cites this paper
• Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing

  2021cites this paper
• Yap-Myc signaling induces pancreatic stellate cell activation through regulating glutaminolysis.

  2021cites this paper
• Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds

  2021cites this paper
• Supply and demand: Cellular nutrient uptake and exchange in cancer.

  2021cites this paper
• The regulatory networks of the Hippo signaling pathway in cancer development

  2021cites this paper
• Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies

  2021cites this paper
• Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer

  2021cites this paper
• Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response

  2021cites this paper
• Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage

  2021cites this paper
• TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling

  2021cites this paper
• An Updated Understanding of the Role of YAP in Driving Oncogenic Responses

  2021cites this paper
• Genotoxic therapy and resistance mechanism in gliomas.

  2021cites this paper
• Comprehensive understanding of anchorage-independent survival and its implication in cancer metastasis

  2021cites this paper
• Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells

  2021cites this paper
• CMAR_A_293728 5187..5201

  2021cites this paper
• BEX1 and BEX4 Induce GBM Progression through Regulation of Actin Polymerization and Activation of YAP/TAZ Signaling

  2021cites this paper
• Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma.

  2021cites this paper
• The roles of integrins in cancer

  2021cites this paper
• STAT3 Mediated Regulation of Glucose Metabolism in Leukemia Cells.

  2021cites this paper
• Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer

  2021cites this paper
• Elaborating the Physiological Role of YAP as a Glucose Metabolism Regulator:A Systematic Review.

  2021cites this paper
• The Leloir Cycle in Glioblastoma: Galactose Scavenging and Metabolic Remodeling

  2021cites this paper
• A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials

  2021cites this paper
• Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties

  2021cites this paper
• A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1

  2021cites this paper
• Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma

  2021cites this paper